TOP TIERMARKET NEWSWIRE
News & sentiment

MAPLIGHT THERAPEUTIC (MPLT) — News & AI sentiment

MAPLIGHT THERAPEUTIC (MPLT) news roundup. 19 stories in the past week, 21 over 30 days. Average 30-day sentiment is 46.3/100. Recent insider activity (SEC Form 4, 90-day window): 1 purchases totalling $149K and 11 sales totalling $16.9M — net selling of $16.8M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
19
avg sentiment 44.4/100
30d stories
21
avg sentiment 46.3/100
Insider net (90d)
$16.8M
1 buys · 11 sells
Congress (90d)
0
0 buys · 0 sells

Latest stories on MPLT

BMO cuts MapLight Therapeutics price target on trial results
Investing.com Analyst Ratings34 · bearishanalyst
2d ago
Canaccord cuts MapLight Therapeutics stock price target on trial data
Investing.com Analyst Ratings38 · neutralanalyst
2d ago
2d ago
2d ago
2d ago
2d ago
Wolfe cuts MapLight Therapeutics stock price target on trial data
Investing.com Analyst Ratings38 · neutralanalyst
2d ago
3d ago
3d ago
Jefferies reiterates MapLight Therapeutics stock rating on trial data
Investing.com Analyst Ratings56 · neutralanalyst
3d ago
3d ago
BMO reiterates Outperform on MapLight stock after trial data
Investing.com Analyst Ratings63 · neutralanalyst
3d ago
3d ago
3d ago
3d ago
3d ago
MapLight Therapeutics stock tumbles 40% on trial results
Investing.com Markets32 · bearishearnings
3d ago
3d ago
3d ago
UBS raises MapLight Therapeutics stock price target on trial data
Investing.com Analyst Ratings63 · neutralanalyst
Jul 21
Jun 30
Jun 25
Jun 25
Jun 24
Jun 24
Open MPLT in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →